Silver nanoparticles (NPs) have been widely explored as antibacterial and antifungal agents in households, cosmetics, food packaging, medical devices and even various wound care products. With the application of silver NPs in biomedicine expanding, the safety issue is attracting ever-growing attention. Although increasing literatures have evidenced that silver NPs induce reactive oxygen species (ROS) in mammalian cells and thus resulted in cell damage, mechanisms of how these nanoparticles initiate ROS accumulation are open questions. In this work, we found an important pathway of initiating ROS overproduction. Gold nanorod core/silver shell nanostructures (herein termed as Ag nanorods, AgNRs) were employed as a model for silver NPs and NIH3T3 fibroblast cell line was chosen as mammalian cell model. Upon exposure to the AgNRs, the cell membrane of the fibroblasts was disrupted along with generation of malondialdehyde (MDA), possibly due to the dissolution of silver ions from AgNRs surface. Consequently, actin depolymerization in the cytoskeleton connecting tightly with the membrane occurred. The membrane damage allowed calcium influx and induced intracellular calcium overload, which further caused ROS overproduction and mitochondrial membrane potential variation. All these complex stresses eventually resulted in cell death through apoptosis in a dose-dependent manner.
1 March 2017 in ACS Applied Materials & Interfaces
Inspired by cisplatin's deactivation by glutathione (GSH) in cancer, a GSH responsive nanogel loaded with doxorubicin (Dox) was prepared using hyaluronan as a matrix and cisplatin as a crosslinker.
Breast cancer is the most common malignant disease in women, and it is not the primary tumor but its metastasis kills most patients with breast cancer. Anti-metastasis therapy based on RNA interference (RNAi) is emerging as one of promising strategies in tumor therapy. However, construction of an efficient delivery system for siRNA is still one of the major challenges. In this work, siRNA against protease-activated receptor-1 (PAR-1) which is a pivotal gene involved in tumor metastasis was conjugated to gold nanorods (AuNRs) via electrostatic interaction and delivered to highly metastatic human breast cancer cells. It was demonstrated that the siRNA oligos were successfully delivered into the cancer cells and mainly located in vesicle-like structures including lysosome. After transfected with the complex of AuNRs and PAR-1 siRNA (AuNRs@PAR-1 siRNA), expression of PAR-1 at both mRNA and protein levels were efficiently down regulated, as evidenced by quantitative real time PCR and flow cytometry analysis, respectively. Transwell migration assay confirmed the decrease in metastatic ability of the cancer cells. The silencing efficiency of the complex was in-between that of TurboFect and Lipofectamine, however, the cytotoxicity of the AuNRs was lower than that of the latter two. Taken together, AuNRs with PAR-1 siRNA are suited for RNAi based anti-metastasis therapy.